Translational Molecular Nuclear Cardiology

James T. Thackeray, Frank M. Bengel

Research output: Contribution to journalReview article

Abstract

Increased rollout and availability of preclinical imaging provides a foundation for development of novel molecular nuclear imaging agents. The current armamentarium of radiotracers available for nuclear cardiology allows for the interrogation of critical molecular processes involved in a myriad of cardiovascular disorders, including altered metabolism, ventricular remodeling, sympathetic neuronal activation, and systemic inflammation. Effective translational molecular imaging requires coordination of clinical need with tracer development and molecular biology, leading to the identification of ideal translational imaging compounds.

Original languageEnglish (US)
Pages (from-to)187-198
Number of pages12
JournalCardiology clinics
Volume34
Issue number1
DOIs
StatePublished - Feb 2016

Keywords

  • Cardiovascular disease
  • PET
  • SPECT
  • Translational imaging

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Translational Molecular Nuclear Cardiology'. Together they form a unique fingerprint.

  • Cite this